This article has been corrected: The authors recently found that panels H and J in Figure 2 are the same, as they accidentally placed normalized WM plot instead of normalized GM plot. They replaced panel H Figure 2 with the correct plot from the original data. This alteration does not affect the results or conclusions of this work.

New Figure 2 is presented below.

Correlation analysis between serum GH/IGF-1 levels and brain tissue volume in patients with GH-PA and patients with NonFun-PA groups. The normalized GM volume (nGMV) shows significant positive correlation with GH (A) and IGF-1 (B) in patients with GH-PA. The normalized WM volume (nGWV) shows no significant correlation with GH (C) or IGF-1 (D) in patients with GH-PA. The normalized CSF volume (nCSFV) shows significant negative correlation with GH (E) and IGF-1 (F) in patients with GH-PA. In patients with NonFun-PA, nGMV, nWMV, and nCSFV show no significant correlation with GH/IGF-1 (G–L).

Figure 2. Correlation analysis between serum GH/IGF-1 levels and brain tissue volume in patients with GH-PA and patients with NonFun-PA groups. The normalized GM volume (nGMV) shows significant positive correlation with GH (A) and IGF-1 (B) in patients with GH-PA. The normalized WM volume (nGWV) shows no significant correlation with GH (C) or IGF-1 (D) in patients with GH-PA. The normalized CSF volume (nCSFV) shows significant negative correlation with GH (E) and IGF-1 (F) in patients with GH-PA. In patients with NonFun-PA, nGMV, nWMV, and nCSFV show no significant correlation with GH/IGF-1 (G–L).